$PBIO The details of the PCT-enhanced MMS workflow
Post# of 53474
(Total Views: 169)
Posted On: 04/29/2020 6:19:28 AM
$PBIO The details of the PCT-enhanced MMS workflow are described in an online webinar (Click Here) and in a publication in Genetic Engineering and Biotechnology News (Click Here).
About RedShiftBio.
RedShiftBio® is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins. The patented MMS technology provides comprehensive secondary structure information across five key measurements, in a single automated analysis, replacing the requirement to run samples on multiple instruments. For further information, please visit www.redshiftbio.com/ or email info@redshiftbio.com.
https://www.otcmarkets.com/stock/PBIO/news/Pr...?id=259357
About RedShiftBio.
RedShiftBio® is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins. The patented MMS technology provides comprehensive secondary structure information across five key measurements, in a single automated analysis, replacing the requirement to run samples on multiple instruments. For further information, please visit www.redshiftbio.com/ or email info@redshiftbio.com.
https://www.otcmarkets.com/stock/PBIO/news/Pr...?id=259357
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼